These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35588190)

  • 1. Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study.
    Sinn DH; Kang D; Kang M; Guallar E; Hong YS; Lee KH; Park J; Cho J; Gwak GY
    Hepatology; 2022 Dec; 76(6):1746-1754. PubMed ID: 35588190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.
    Lee MJ; Kim EH; Bae SJ; Kim GA; Park SW; Choe J; Jung CH; Lee WJ; Kim HK
    Gut Liver; 2019 Jan; 13(1):67-76. PubMed ID: 30037166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.
    Kim G; Lee SE; Lee YB; Jun JE; Ahn J; Bae JC; Jin SM; Hur KY; Jee JH; Lee MK; Kim JH
    Hepatology; 2018 Nov; 68(5):1755-1768. PubMed ID: 29679374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities.
    Han E; Lee YH; Ahn SH; Cha BS; Kim SU; Lee BW
    Gut Liver; 2024 May; 18(3):509-519. PubMed ID: 38013477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.
    Alferink LJM; Trajanoska K; Erler NS; Schoufour JD; de Knegt RJ; Ikram MA; Janssen HLA; Franco OH; Metselaar HJ; Rivadeneira F; Darwish Murad S
    J Bone Miner Res; 2019 Jul; 34(7):1254-1263. PubMed ID: 31074909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
    Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in skeletal muscle mass is associated with hepatic steatosis in nonalcoholic fatty liver disease.
    Jo IH; Song DS; Chang UI; Yang JM
    Sci Rep; 2023 Apr; 13(1):6920. PubMed ID: 37117864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PNPLA3 rs738409 C>G variant influences the association between low skeletal muscle mass and NAFLD: the Shanghai Changfeng Study.
    Xia MF; Chen LY; Wu L; Ma H; Li Q; Aleteng Q; Hu Y; He WY; Gao J; Lin HD; Gao X
    Aliment Pharmacol Ther; 2019 Sep; 50(6):684-695. PubMed ID: 31250467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
    Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
    J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus.
    Zhang X; He Z; Si Q; Hu X; Yang L; Gu X; Du L; Wang L; Pan L; Li Y; Li J; Yang B; Gu X
    J Diabetes Res; 2022; 2022():2229139. PubMed ID: 36387941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
    Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
    Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty liver disease in male.
    Pan XY; Liu WY; Zhu PW; Li G; Tang LJ; Gao F; Huang OY; Yuan HY; Targher G; Byrne CD; Wang XD; Zheng MH
    Hepatol Int; 2022 Oct; 16(5):1085-1093. PubMed ID: 35829867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of non-alcoholic fatty liver disease on the risk of sarcopenia: a nationwide multicenter prospective study.
    Roh E; Hwang SY; Yoo HJ; Baik SH; Lee JH; Son SJ; Kim HJ; Park YS; Lee SG; Cho BL; Jang HC; Kim BJ; Kim M; Won CW; Choi KM
    Hepatol Int; 2022 Jun; 16(3):545-554. PubMed ID: 34780030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease.
    Kang MK; Park JG; Lee HJ; Kim MC
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1633-1640. PubMed ID: 30667551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Sarcopenia and Its Defining Components in Non-alcoholic Fatty Liver Disease Varies According to the Method of Assessment and Adjustment: Findings from the UK Biobank.
    Freer CL; George ES; Tan SY; Abbott G; Scott D; Daly RM
    Calcif Tissue Int; 2024 Jun; 114(6):592-602. PubMed ID: 38678512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between muscle mass, strength, and performance and non-alcoholic fatty liver disease.
    Rigor J; Vasconcelos R; Lopes R; Moreira T; Barata P; Martins-Mendes D
    Minerva Gastroenterol (Torino); 2023 Sep; 69(3):374-381. PubMed ID: 35343663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease.
    Chung GE; Kim MJ; Yim JY; Kim JS; Yoon JW
    J Obes Metab Syndr; 2019 Jun; 28(2):129-138. PubMed ID: 31294345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity.
    Kim HK; Bae SJ; Lee MJ; Kim EH; Park H; Kim HS; Cho YK; Jung CH; Lee WJ; Choe J
    Clin Mol Hepatol; 2023 Oct; 29(4):987-1001. PubMed ID: 37403320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease.
    Gan D; Wang L; Jia M; Ru Y; Ma Y; Zheng W; Zhao X; Yang F; Wang T; Mu Y; Zhu S
    Clin Nutr; 2020 Apr; 39(4):1124-1130. PubMed ID: 31053512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Serum Vitamin D Level with Sarcopenia, Non-Alcoholic Fatty Liver Disease (NAFLD), and Sarcopenia in NAFLD Among People Aged 50 Years and Older: The Korea National Health and Nutrition Examination Survey IV-V.
    Hong J; Shin WK; Lee JW; Lee SY; Kim Y
    Metab Syndr Relat Disord; 2022 May; 20(4):210-218. PubMed ID: 35100057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.